Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,050 public trials 714 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

NCT06353347

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Baogang Hospital of Inner Mongolia Baotou, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, China
  • Beijing Luhe Hospital Capital Medical University Beijing, China
  • Beijing Pinggu Hospital Beijing, China
View all 64 locations
View Trial Details
Completed

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

NCT05035082

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Stewart Medical Group Alhambra, California, United States
  • FDRC Costa Mesa, California, United States
  • Scripps Whittier Diabetes Inst La Jolla, California, United States
  • Raincross Medical Group Riverside, California, United States
View all 25 locations
View Trial Details
Completed

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

NCT06066528

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • EmVenio Research-Atlanta-69582 Phoenix, Arizona, United States
  • Encompass Clinical Research, Spring Valley Spring Valley, California, United States
  • Diablo Clinical Research Walnut Creek, California, United States
View all 143 locations
View Trial Details
Completed

LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes

NCT05313529

Conditions
Cognition Disorders, Cognitive Dysfunction, Diabetes Mellitus, +9 more
Locations
  • Department of Endocrinology, Changzhou No.2 People's Hospital, the Affiliated Hospital of Nanjing Medical University Changzhou, Jiangsu, China
  • Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University Nanjing, Jiangsu, China
  • Department of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu, China
  • Department of Endocrinology, the Affiliated Jiangning Hospital of Nanjing Medical University Nanjing, Jiangsu, China
View Trial Details

Related conditions